X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
J. B. CHEMICALS & PHARMACEUTICALS LTD. Fact Sheet - Equitymaster
Investing in India? Get Equitymaster Research  

J. B. CHEMICALS & PHARMACEUTICALS LTD.  (JBCH)


Here is the latest financial fact sheet of J.B.Chemicals. For more details, see the J.B.Chemicals quarterly results and J.B.Chemicals share price and chart. For a sector overview, read our pharmaceuticals sector report.
 
J.B.CHEMICALS - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 329.0       No. of shares m 84.80
    Mkt Cap Rs m 27,899       % ch % -0.6
    Vol '000 15.3       % ch week % -1.0
    P/E X 16.0       % ch 1-mth % -3.9
    P/CF X 13.7       % ch 12-mth % 31.1
    EPS (TTM) Rs 20.5       52 week H/L Rs 403.6/231.0
(As on Apr 28, 2017 03:29:00 PM) »  Best Performing pharmaceuticals Stocks

Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Mar-12
*
12
Mar-13
*
12
Mar-14
*
12
Mar-15
*
12
Mar-16
*
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs18596142258318 
Low Rs585973129200 
Sales per share (Unadj.) Rs94.7102.2120.6134.9148.0 
Earnings per share (Unadj.) Rs80.09.47.311.819.1 
Diluted earnings per shareRs79.99.47.311.819.1 
Cash flow per share (Unadj.) Rs82.712.310.616.423.9 
Dividends per share (Unadj.) Rs41.003.003.0014.000.50 
Adj. dividends per shareRs40.963.003.0014.000.50 
Dividend yield (eoy) %33.73.92.87.20.2 
Book value per share (Unadj.) Rs114.5120.4123.1117.3128.9 
Adj. book value per shareRs114.4120.3123.0117.3129.0 
Shares outstanding (eoy) m84.7184.7184.7384.8184.82 
Bonus/Rights/Conversions  ESOS-ESOPESOP- 
Price / Sales ratio x1.30.80.91.41.7 
Avg P/E ratio x1.58.314.816.313.6 
P/CF ratio (eoy) x1.56.310.111.810.8 
Price / Book Value ratio x1.10.60.91.62.0 
Dividend payout %51.232.041.3118.32.6 
Avg Mkt Cap Rs m10,2926,5829,07916,38121,951 
No. of employees `0003.52.42.52.22.7 
Total wages/salary Rs m1,1271,3011,4371,5961,841 
Avg. sales/employee Rs Th2,321.53,571.74,120.45,302.24,590.9 
Avg. wages/employee Rs Th326.2536.3579.3739.4673.4 
Avg. net profit/employee Rs Th1,962.7327.6248.0465.3592.1 
  INCOME DATA
Net Sales Rs m8,0198,66110,21911,44212,551 
Other income Rs m290279377109542 
Total revenues Rs m8,3088,94010,59611,55113,093 
Gross profit Rs m1,0031,0571,4851,7922,055 
Depreciation Rs m224247280386412 
Interest Rs m24053625996 
Profit before tax Rs m8291,0361,5201,4562,088 
Minority Interest Rs m00000 
Prior Period Items Rs m1102100 
Extraordinary Inc (Exp) Rs m7,6060-64500 
Tax Rs m1,666241281451469 
Profit after tax Rs m6,7797956151,0041,619 
Gross profit margin %12.512.214.515.716.4 
Effective tax rate %201.123.318.531.022.5 
Net profit margin %84.59.26.08.812.9 
  BALANCE SHEET DATA
Current assets Rs m8,6629,4379,8079,0097,778 
Current liabilities Rs m1,8832,3952,7634,5984,358 
Net working cap to sales %84.581.368.938.627.2 
Current ratio x4.63.93.52.01.8 
Inventory Days Days4644484855 
Debtors Days Days6281848480 
Net fixed assets Rs m3,1533,3923,5693,8385,713 
Share capital Rs m169169169170170 
"Free" reserves Rs m9,2149,71110,0379,53110,547 
Net worth Rs m9,70010,20310,4289,94910,937 
Long term debt Rs m12672540 
Total assets Rs m11,97813,00213,51014,87215,574 
Interest coverage x4.420.625.425.522.8 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.80.80.8 
Return on assets %58.66.55.07.211.0 
Return on equity %69.97.85.910.114.8 
Return on capital %88.410.69.215.220.0 
Exports to sales %41.353.954.350.648.7 
Imports to sales %8.05.88.48.87.1 
Exports (fob) Rs m3,3084,6645,5465,7876,115 
Imports (cif) Rs m6415028611,006889 
Fx inflow Rs m3,5584,7555,6055,8336,169 
Fx outflow Rs m1,5031,0891,5691,3881,285 
Net fx Rs m2,0553,6654,0374,4454,884 
  CASH FLOW
From Operations Rs m 8,797 842 -140 1,267 1,397 
From Investments Rs m -2,609 -1,161 -1,425 -1,119 -320 
From Financial Activity Rs m -5,261 -315 120 -14 -1,196 
Net Cashflow Rs m 926 -633 -1,444 134 -102 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for j. b. chemicals & pharmaceuticals ltd.

 Share Holding
Indian Promoters : 55.4%
Foreign collaborators : 0.3%
Indian inst/Mut Fund : 3.4%
FIIs : 3.9%
ADR/GDR : 0.0%
Free float : 37.0%
Shareholders : 30,437
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: Neelam Centre, 4th Floor, B-Wing, Hind Cycle Road, Worli, Mumbai - 400 030
    E-MAIL: investorelations@jbcpl.com     WEB: www.jbcpl.com
    TELEPHONE: (022) 3045 1200     FAX: (022) 2493 0534
    SECTOR: PHARMACEUTICALS     GROUP: MISCELLANEOUS
    TR AGENT: Datamatics, No. B-5, MIDC, Part B, Cross Lane, Andheri (E), Mumbai-93
    AUDITOR: J. K. Shah & Co.
CHM: Durga Dass Chopra COMP SEC: M. C. Mehta YEAR OF INC: 1976 BSE CODE: 506943 FV (Rs): 2 DIV YIELD (%): 0.2

More pharmaceuticals Company Fact Sheets:   ELDER PHARMACIPLAAJANTA PHARMAINDOCO REMEDIESDISHMAN PHARMA


Today's Market

Sensex Trades in Red; Metal Stocks Witness Buying(01:30 pm)

After opening the day on a negative note, share markets in India have continued the downtrend and are trading below the dotted line.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

We Don't Want More F&O Stocks... We Need Smaller Lot Sizes(Daily Profit Hunter)

Apr 26, 2017

Are you excited to trade in the sixteen new stocks to be introduced in the F&O segment this Friday?

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON J.B.CHEMICALS

J.B.CHEMICALS 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE J.B.CHEMICALS WITH

MARKET STATS